{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T04:20:49Z","timestamp":1774930849915,"version":"3.50.1"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","issue":"10","funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R21AR072831-01"],"award-info":[{"award-number":["1R21AR072831-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01GM108893"],"award-info":[{"award-number":["R01GM108893"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["MC"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Bone loss is the most common reason for broken bones among the elderly.\nAn ideal agent for the treatment of bone loss should have both osteoclast inhibitory and osteoblast\nstimulatory functions. Leucine-rich repeat kinase 1 (LRRK1) is a novel target for alternative antiresorptive\ndrugs to treat osteoporosis and osteoporotic fractures. Recently a chemical IN04, Methyl\n3-[(([5-(3,5-dimethoxyphenyl)-1,3,4-oxadiazol-2-yl]-thio-acetyl)-amino]-benzoate, has been identified\nas a potential LRRK1 inhibitor.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>The aim of this work is to investigate how the chemical IN04 interacts with LRRK1 and\ninhibits its activity.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>A structural model of the LRRK1 kinase domain was constructed with SWISS-MODEL.\nThe human protein kinase ROCO4 (PDB ID: 4YZN) was chosen as the template based on sequence\nhomology, structural and phylogenetic analysis. In addition, a homology model of the LRRK1 ROC\ndomain was also prepared based on the LRRK2 ROC domain structure (PDB ID: 2ZEJ). The interactions\nof IN04 with the active sites in the LRRK1 kinase domain and ROC domain were investigated\nby SwissDock.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>IN04 was docked into the active site of the LRRK1 kinase domain with similar interactions\nas ATP comparable to the ligand bound to homologous kinases. Many rational binding modes of\nIN04 to LRRK1 kinase domain were investigated and the most likely binding pose containing multiple\nhydrogen bonds and a salt bridge was discovered. However, IN04 cannot fit into the GDP-binding\nsite of the ROC domain.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Chemical IN04 inhibits LRRK1 by binding to the active site of the kinase domain but\nnot the ROC domain.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1573406416666200924125620","type":"journal-article","created":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T04:59:29Z","timestamp":1601009969000},"page":"1140-1150","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chemical IN04 Inhibits the Kinase Domain not the ROC Domain of LRRK1: Results from Homology Modeling and Molecular Docking"],"prefix":"10.2174","volume":"17","author":[{"given":"Zhenhang","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Biochemistry, University of California Riverside, Riverside, CA, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weirong","family":"Xing","sequence":"additional","affiliation":[{"name":"Department of Medicine, Loma Linda University, Loma Linda, CA, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6763-0467","authenticated-orcid":true,"given":"Li","family":"Fan","sequence":"additional","affiliation":[{"name":"Department of Biochemistry, University of California Riverside, Riverside, CA, United States"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","container-title":["Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/eurekaselect.com\/article\/download\/186254","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/186254\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eurekaselect.com\/article\/download\/186254","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T16:51:41Z","timestamp":1637340701000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/186254\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573406416666200924125620","relation":{},"ISSN":["1573-4064"],"issn-type":[{"value":"1573-4064","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-06-05","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-17","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}